Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort - Marta Hernández-Conde, Inmaculada Fernández, Christie Perelló, Adolfo Gallego, Martin Bonacci, Juan M. Pascasio, Manuel Romero-Gómez, Susana Llerena, Conrado Fernández-Rodríguez, José L. Castro Urda, Luisa García Buey, Isabel Carmona, Rosa M. Morillas, Nuria Domínguez García, Francisco Gea - Dissemin

Language
Login

Published in

Wiley, Journal of Viral Hepatitis, 1(26), p. 55-64, 2018

DOI: 10.1111/jvh.13008

Links

ORCID
Wiley

Tools

Export citation

Search in Google Scholar

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

Journal article published in 2018 by Marta Hernández-Conde, Inmaculada Fernández, Christie Perelló, Adolfo Gallego, Martin Bonacci, Juan M. Pascasio, Manuel Romero-Gómez, Susana Llerena, Conrado Fernández-Rodríguez, José L. Castro Urda, Luisa García Buey, Isabel Carmona, Rosa M. Morillas, Nuria Domínguez García, Francisco Gea and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO